Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Atreca, Inc. - Class A Common Stock (NQ: BCEL )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Atreca, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 Next >
Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb Cross
From Atreca, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 14, 2023
Via Benzinga
Analyst Expectations for Atreca's Future
Via Benzinga
Recap: Atreca Q1 Earnings
Via Benzinga
Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Amyris, Inc. (NASDAQ: AMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy. 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
The Latest Analyst Ratings for Atreca
Via Benzinga
Preview: Atreca's Earnings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023
Via Benzinga
Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate Restructuring
From Atreca, Inc.
Via GlobeNewswire
3 Penny Stocks to Catapult You Into the Millionaires’ Club
These penny stocks can deliver tremendous upside from their depressed range. Wall Street analysts can back it up! 
Via InvestorPlace
Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 209.5% to $2.29 after the company signed a Letter of Intention with UAE-Based e-script medicine management company Pharmak... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual Meeting
From Atreca, Inc.
Via GlobeNewswire
Atreca Reports First Quarter 2023 Financial Results and Recent Corporate Developments
From Atreca, Inc.
Via GlobeNewswire
Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual Meeting
From Atreca, Inc.
Via GlobeNewswire
Atreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
From Atreca, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
Via Benzinga
Philip Morris To Rally Over 22%? Here Are 10 Other Analyst Forecasts For Thursday
Chardan Capital cut the price target for Synlogic, Inc. (NASDAQ: SYBX) from $7 to $5.5. Chardan Capital analyst Keay Nakae maintained a Buy rating. Synlogic shares gained 2.9% to close at $0.63 on... 
Via Benzinga
Atreca Reports Fourth Quarter and Full-Year 2022 Financial Results and ATRC-101 Data Update
From Atreca, Inc.
Via GlobeNewswire
Atreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023
Call/webcast to feature updates on the discovery platform and pipeline, including updated data from the ongoing Phase 1b trial of ATRC-101 
From Atreca, Inc.
Via GlobeNewswire
Atreca to Participate at Cowen’s 43rd Annual Health Care Conference
From Atreca, Inc.
Via GlobeNewswire
Why Is T2 Biosystems (TTOO) Stock Down 21% Today?
T2 Biosystems (TTOO) stock is falling hard on Tuesday as investors react to a proposed public offering from the company. 
Via InvestorPlace
Why Is Atreca (BCEL) Stock Up Today?
Atreca (BCEL) stock is getting a boost on Tuesday as the biopharmaceutical company continues a recent rally connected to insider buying. 
Via InvestorPlace
Why Fusion Pharmaceuticals Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start another day of trading with a breakdown of the biggest pre-market stock movers investors need to watch for Tuesday! 
Via InvestorPlace
Atreca and Xencor to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor Target
From Atreca, Inc.
Via GlobeNewswire
Atreca Appoints Philippe Bishop, MD as Chief Medical Officer
From Atreca, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.